Catalog #: custom peptides synthesis:peptide name# peptide, 3X5MG = 15MG,>95%, lot# 120489-120510.
Ended Purchase Order Awarded
- Contract number
- 75N95020P00526
- Awardee
-
Genemed Synthesis, Inc. UEI W8CGAPUG5YK5
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $23,895
Award facts
- Contract value 100% obligated
- $23,895.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- PSC
- 6810 Chemicals
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Baltimore, MD 21224, USA
Award details come from SAM.gov/FPDS.
Quick answers
Who was awarded contract 75N95020P00526?
75N95020P00526 was awarded to Genemed Synthesis, Inc. by National Institute on Drug Abuse (National Institutes of Health) on September 1, 2020.
How much is contract 75N95020P00526 worth?
The government has obligated $23,895 on 75N95020P00526.
Was contract 75N95020P00526 competed?
The extent of competition for 75N95020P00526 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award